Research > ETFs > ETF / ETP Commentary > 

Top Performing Leveraged/Inverse ETFs: 11/17/2024

Top Performing Levered/Inverse ETFs Last WeekThese were last week’s top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly. Always do your homework.1. LABD – Direxion Daily S&P Biotech Bear 3x Shares The biotech fund, LABD which offers inverse exposure to the US Biotechnology sector gained ~42% last week. Healthcare was the worst-performing sector registering a decline of ~5% in the last five days and the Biotech sector fell more than 7%. Healthcare stocks fell after President-elect Donal Trump appointed anti-vaccine activist Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Investors fear that his administration will prioritize deregulation and increased market competition in healthcare. 2. BITX – 2X Bitcoin Strategy ETF BITX, which seeks daily investment results, before fees and expenses, that correspond to two times the excess return of the S&P CME Bitcoin Futures Daily Roll Index, ranked second on the leveraged ETFs’ list with ~39% returns last week. Trump’s crypto-enthusiasm, both on the campaign trail and in his investments, is fueling speculation that his administration will adopt crypto-friendly policies, drawing investors to the market. 3. BITU – ProShares Ultra Bitcoin ETF BITU was another crypto-fund on the list of leveraged ETFs last week as Bitcoin gained momentum with Donald Trump winning the election in November. 4. SOXS – Direxion Daily Semiconductor Bear 3x Shares The SOXS ETF inversely tracks the PHLX Semiconductor Index featured on the list of levered/ inverse ETFs with ~30% returns in the last week as Applied Materials’s forecasted revenue range fell short of analysts’ expectations. The semiconductor sector fell by more than ~4.5% and the broader Technology sector also registered a fall of over ~2%. 5. GDXD – MicroSectors Gold Miners -3X Inverse Leveraged ETNs GDXD, which offers inverse leveraged exposure to Global Gold Miners, was one of the top performing levered/ inverse ETFs returning ~30% last week. Higher inflation could prompt the Fed to slow down its easing, boosting the dollar and weighing on gold prices. 6. BIS – ProShares UltraShort Nasdaq Biotechnology BIS ETF which offers 2x daily short leverage to the broad-based NASDAQ Biotechnology Index was another Biotech ETF on the list with ~23% weekly gains. 7. CONL – GraniteShares 1.5x Long Coinbase Daily ETF CONL ETF provides 1.5x leveraged exposure to the daily price movement for shares of Coinbase stock also featured on the list with nearly ~21.5% weekly returns. Cryptocurrencies rallied following Donald Trump’s reelection, driven by hopes of a more favorable regulatory climate. 8. DUST – Direxion Daily Gold Miners Index Bear 2x Shares DUST which provides inverse levered exposure to Global Gold Miners was another top inverse ETF returning ~20% last week amid a strong dollar. 9. JDST – Direxion Daily Junior Gold Miners Index Bear 2X Shares Direxion Daily Junior Gold Miners Index Bear 2X Shares or JDST, which seeks daily investment results of 200% of the inverse of the performance of the MVIS Global Junior Gold Miners Index also featured on the top performing inverse ETFs’ list, returning ~19% in the last week. 10. DULL – MicroSectors Gold -3X Inverse Leveraged ETNs DULL ETN provides 3x daily inverse leveraged exposure to the spot price of gold by tracking GLD and was another top performing inverse fund with ~14% in weekly gains. For more news, information, and analysis, visit the Leveraged & Inverse Channel.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.